Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence after Liver Transplantation

The availability of HBIG and several oral antiviral therapies have reduced but not eliminated HBV recurrence. We aimed to determine the rate of HBV recurrence after orthotopic liver transplantation (OLT) in relation to virologic breakthrough pre-OLT and HBIG regimens post-OLT. Data from the NIH HBV-...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Degertekin, Bulent, Han, Steven-Huy B., Keeffe, Emmet B., Schiff, Eugene R., Luketic, Velimir A., Brown, Robert S., Emre, Sukru, Soldevila-Pico, Consuelo, Reddy, K. Rajender, Ishitani, Michael B., Tran, Tram T., Pruett, Timothy L., Lok, Anna S. F.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2910807/
https://ncbi.nlm.nih.gov/pubmed/20346062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2010.03046.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki